FEATURES OF CELLS’ BELONGING TO INNATE AND ADAPTIVE IMMUNE SYSTEMS RATIO IN PATIENTS WITH PITUITARY ADENOMAS

Authors

  • I.A. Gnedkova The State Institution Romodanov Neurosurgery Institute, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • N.I. Lisyanyi The State Institution Romodanov Neurosurgery Institute, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • A.A. Shmeleva The State Institution Romodanov Neurosurgery Institute, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • V.V. Vaslovych The State Institution Romodanov Neurosurgery Institute, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
  • M.A. Gnedkova The State Institution Romodanov Neurosurgery Institute, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine

DOI:

https://doi.org/10.32471/oncology.2663-7928.t-22-1-2020-g.8753

Keywords:

leukocytes, lymphocytes, neutrophils, NLR ratio, pituitary adenoma, pituitary-adrenal system, platelets, менингиома

Abstract

Hormones of the hypothalamic-pituitary-­adrenal system (HPA) are involved in maintenance of body homeostasis and modulation of inflammation and immune response reactions. The direction of hormones effects on cells of innate and adaptive immunity to some extent is reflected in neutrophils and lymphocytes content ratio (NLR) in the peripheral blood (PB). Earlier we have studied and analyzed the changes in ratio of before mentioned cells in PB of patients with brain tumors depending on histogenetic origin and malignancy grade, but patients with pituitary adenoma (PA) were not included. Aim: to study content and features of blood cells ratio (platelets (PLT), leukocytes (WBC), neutrophils (NEUT), lymphocytes (LYMPH)) in patients with PA comparing to patients with meningioma and glioblastoma in the preoperative, postoperative periods and with continued tumor growth. Object and methods: parameters of PB were studied in 122 patients (age 32–67) of whom 18 patients were diagnosed with PA, 40 patients with glioblastoma, 25 with meningioma, 28 with non-oncological diseases of the central nervous system (the comparison group). PB cells count was performed on a MINDRAY BC-3000 plus automatic hematology analyzer (China). The total content of PLT, NEUT and LYMPH, relative content (%) of NEUT and LYMPH, NLR (%) ratio and PLR and PNR indexes were determined. Results: in patients with different stages of PA, the content of PLT, WBL, total and relative content of NEUT and LYMPH in the PB did not differ statistically significantly from the comparison group. PLT indexes of patients with tumors of different histostructure also did not differ significantly. In patients with PA, WBC content, total and relative count of NEUT was lower, while the LYMPH count was higher as compared to patients with meningioma and glioblastoma in similar stages of the disease. In patients with PA, signs of adaptive immunity activation were noted — a significant decrease in NLR and PLT ratios with continued tumor growth. High NLR ratio, indicating the predominant activation of innate immunity, was noted in patients with glioblastoma. Conclusion: in patients with different stages of PA as well as with continued meningioma growth, reactions of adaptive immune responses are activated. In patients with glioblastoma, reactions of innate immunity are activated at all clinical stages of the disease. The NLR ratio reflects activity of innate and adaptive immunity as well as the balance and direction of HPA hormones with pro- and anti-inflammatory activity influence on the immune system of a particular patient.

 

References

Andela CD, Lobatto DJ, Pereira AM, et al. How non-functioning pituitary adenomas can affect health-related quality of life:

a conceptual model and literature review. Pituitary 2018; 21 (2):

–16.

Lupi I, Manetti L, Caturegli P, et al. Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor

clinical outcome after surgery in patients with pituitary adenoma.

J Clin Endocrinol Metab 2010; 95 (1): 289–96.

Smith EM. Neuropeptides as signal molecules in common

with leukocytes and the hypothalamic-pituitary-adrenal axis. Brain

Behav Immun 2008; 22 (1): 3–14.

Dantzer R. Neuroimmune interactions: from the brain to the

immune system and vice versa. Physiol Rev 2018; 98 (1): 477–504.

Kriy J. Biochimie: etudes medicates et biologues. Moscow:

Medicina, 1979. 510 р. (in Russian)

Polyakova V, Kvetnoy IM, Anderson G, et al. Reciprocal interactions of mitochondria and the neuroimmunoendocrine system in neurodegenerative disorders: an important role for melatonin

regulation. Front Physiol 2018; 9: doi: 10.3389/fphys.2018.00199.

Dogadin SA, Dudina MA,Savchenko VA. Intercommunication of somatotropic function of hypophysis and immune system.

Their role is in development of neoplasis. Problems of endocrinol

; 1: 30–4. (in Russian)

Bodart G, Farhat K,Renard-Charlet C, et al. The Severe

deficiency of the somatotrope GH-releasing hormone/growth

hormone/insulin-like growth factor 1 axis of ghrh−/− mice is associated with an important splenic atrophy and relative B lymphopenia Front Endocrinol (Lausanne) 2018; 9: doi: 10.3389/

fendo.2018.00296

Borba VV, Zandman-Goddard G, Shoenfeld Y. Prolactin

and autoimmunity. Front Immunol 2018; 12 (9): doi: 10.3389/

fimmu.2018.00073.

Milani AT, Khadem-Ansari MH, Rasmi Y. Effects of thyroid-stimulating hormone on adhesion molecules and pro-inflammatory cytokines secretion in human umbilical vein endothelial

cells. Res Pharm Sci 2018; 13 (6): 546–56.

Harle G, Kaminski S, Dubayle D, et al. Murine splenic B

cells express corticotropin-releasing hormone receptor 2 that affect their viability during a stress response. Sci Rep 2018; 8: 143.

Laakko T, Fraker P. Rapid changes in the lymphopoietic

and granulopoietic compartments of the marrow caused by stress

levels of corticosterone Immunology. 2002; 105 (1):111–119.

doi: 10.1046/j.1365-2567.2002.01346.x

Jurberg AD, Cotta-de-Almeida V, Temerozo JR, et al. Neuroendocrine control of macrophage development and function.

Front Immunol 2018; 9: 1440.

Pozzo ED, Giacomelli Ch, Cavallini Ch, et al. Cytokine

secretion responsiveness of lymphomonocytes following cortisol

cell exposure: sex differences. PLoS One 2018; 13 (7): e0200924.

Busillo JM, Cidlowski JA. The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and

restore. Trends Endocrinol Metab 2013; 24 (3): 109–19.

Quatrini L, Vivier E, Ugolini S. Neuroendocrine regulation of innate lymphoid cells. Immunol Rev 2018; 286 (1): 120–36.

Gnedkova IA, Lisyaniy NI, Shmeleva AA, et al. Ratio of innate and adaptive immunity cells in peripheral blood in patients

with brain tumors. Oncology 2018; 20 (1): 28–33 (in Russian).

Starr CG, Maderdrut JL, He J, et al. Pituitary adenylate

cyclase-activating polypeptide is a potent broad-spectrum antimicrobial peptide: structure-activity relationships. Peptides. 2018;

: 35–40.

Heshmati HM, Kujas M, Casanova S, et al. Prevalence of

lymphocytic infiltrate in 1400 pituitary adenomas. Endocr J 1998;

(3): 357–61.

Cakir E, Bayindir C, Sabanci PA, et al. Pituitary macroadenoma with persisting dense lymphocytic infiltration in a young

male patient. Clin Neuropathol 2011; 30 (6): 318–23.

Lee F, Yang P-S, Chien M-N, et al. An Increased neutrophil-to-lymphocyte ratio predicts incomplete response to therapy in

differentiated thyroid cancer. Int J Med Sci 2018; 15 (14): 1757–63.

Borowczyk M, Janicki A, Dworacki G, et al. Decreased

staging of differentiated thyroid cancer in patients with chronic

lymphocytic thyroiditis. J Endocrinol Invest 2019; 42 (1): 45–52.

Denef C. Paracrinicity: the story of 30 years of cellular pituitary crosstalk. J Neuroendocrinol 2008; 20 (1): 1–70.

Kasica-Jarosz N, Podlasz P, Kaleczyc J. Pituitary adenylate cyclase–activating polypeptide (PACAP-38) plays an inhibitory role against inflammation induced by chemical damage to zebrafish hair cells. PLoS One 2018; 13 (6): e0198180.

Godoy LD, Rossignoli MT, Delfino-Pereira P, et al. A comprehensive overview on stress neurobiology: basic concepts and

clinical implications. Front Behav Neurosci 2018; 12: 127.

Published

2020-07-01

How to Cite

Gnedkova , I., Lisyanyi , N., Shmeleva , A., Vaslovych , V., & Gnedkova , M. (2020). FEATURES OF CELLS’ BELONGING TO INNATE AND ADAPTIVE IMMUNE SYSTEMS RATIO IN PATIENTS WITH PITUITARY ADENOMAS. Oncology, 22(1-2), 54–59. https://doi.org/10.32471/oncology.2663-7928.t-22-1-2020-g.8753

Issue

Section

Original investigations